Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
An overview of situations where market-cap weighted benchmarks are appropriate and practical tips for effective performance comparison.
28,411 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A fresh forecast places Strategy on a path to 216% upside as bitcoin accumulation accelerates, supported by improving...
Palantir stock isn't cheap, but its AI-driven data platform and strong government foothold create a long‑term thesis ...
A swift market swing tests investors’ nerves and plans. This article unpacks what happened, what history suggests, an...
A landmark bank charter could reshape Circle's business and its stock story. This guidebreaks down what the Circle ju...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
Harmony Gold Mining Stock slid about 12% over the week as gold prices cooled and rate expectations shifted. This arti...
As SPAR Group prepares to report Q4 2025 results, investors seek clarity on growth, margins, and cash flow. This guid...
The market has sprinted higher, and valuations feel stretched. History, however, shows that corrections are a normal ...
DraftKings is diversifying beyond its core betting business. This article examines what that shift could mean for inv...
A UK House of Lords committee calls for lighter regulation on stablecoins to spur innovation and market growth, argui...
A major director sale in a blockchain-focused company can raise questions about risk and opportunity. This deep dive ...